4//SEC Filing
Omrix Biopharmaceuticals, Inc. 4
Accession 0001209191-07-035138
CIK 0001349426operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 10:43 AM ET
Size
8.7 KB
Accession
0001209191-07-035138
Insider Transaction Report
Form 4
PRICE FREDRIC D
Director
Transactions
- Exercise/Conversion
Stock Option
2007-06-04−49,000→ 60,091 totalExercise: $6.19From: 2004-12-17Exp: 2014-12-17→ Common Stock (49,000 underlying) - Sale
Common Stock
2007-06-04$33.80/sh−49,000$1,656,200→ 7,000 total - Exercise/Conversion
Common Stock
2007-06-04$6.19/sh+49,000$303,188→ 56,000 total
Documents
Issuer
Omrix Biopharmaceuticals, Inc.
CIK 0001349426
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349426
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 10:43 AM ET
- Size
- 8.7 KB